Changes in oxidative stress, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats

Brain Research

Volumn 958, Issue 1, 2002, Pages 166-175

  Lerouet, Dominique ^a   Beray Berthat, Virginie ^a   Palmier, Bruno ^a   Plotkine, Michel ^a   Margaill, Isabelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Focal cerebral ischemia; Inducible nitric oxide synthase; Neutrophil; Oxidative stress; Rat

Indexed keywords

CALCIUM; GLUTATHIONE; NITRIC OXIDE SYNTHASE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN FUNCTION; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL ASSAY; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION; TIME; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CALCIUM; CALCIUM SIGNALING; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FREE RADICALS; GLUTATHIONE; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037146917     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03685-5     Document Type: Article

References (78)

1. Abe K., Araki T., Kogure K. Recovery from edema and of protein synthesis differs between the cortex and caudate following transient focal cerebral ischemia in rats. J. Neurochem. 51:1988;1470-1476.
2. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
3. Baldwin Jr A.S. The transcription factor NF-kB and human disease. J. Clin. Invest. 107:2001;3-6.
4. Barber P.A., Auer R.N., Buchan A.M., Sutherland G. Understanding and managing ischemic stroke. Can. J. Physiol. Pharmacol. 79:2001;283-296.
5. Barone F.C., Hillegass L.M., Price W.J., et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29:1991;336-345.
6. Batteur-Parmentier S., Margaill I., Plotkine M. Modulation by nitric oxide of cerebral neutrophil accumulation after transient focal ischemia in rats. J. Cereb. Blood Flow Metab. 20:2000;812-819.
7. Bolaños J.P., Almeida A. Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta. 1411:1999;415-436.
8. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
9. Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA. 86:1989;9030-9033.
10. Candelario-Jalil E., Mhadu N.H., Al-Dalain S.M., Martínez G., León O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41:2001;233-241.
11. Chan P.H. Oxygen radicals in focal cerebral ischemia. Brain Pathol. 4:1994;59-65.
12. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21:2001;2-14.
13. Christman J.W., Blackwell T.S., Juurlink B.H.J. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 10:2000;153-162.
14. Connolly E.S. Jr., Winfree C.J., Springer T.A., et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97:1996;209-216.
15. Connolly E.S. Jr., Winfree C.J., Prestigiacomo C.J., et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ. Res. 81:1997;304-310.
16. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion. Pharmacol. Rev. 53:2001;135-159.
17. Dringen R., Gutterer J.M., Hirrlinger J. Glutathione metabolism in brain. Eur. J. Biochem. 267:2000;4912-4916.
18. Escott K.J., Beech J.S., Haga K.K., Williams S.C.R., Meldrum B.S., Bath P.M.W. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl)imidazole and 7-nitro indazole, after transient focal cerebral ischaemia. J. Cereb. Blood Flow Metab. 18:1998;281-287.
19. Fabian R.H., Kent T.A. Superoxide anion production during reperfusion is reduced by an antineutrophil antibody after prolonged cerebral ischemia. Free Rad. Biol. Med. 26:1999;355-361.
20. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
21. Golanov E.V., Reis D.J. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab. 15:1995;172-174.
22. Graham G.D., Kalvach P., Blamire A.M., Brass L.M., Fayad P.B., Prichard J.W. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke. 26:1995;225-229.
23. Grandati M., Verrecchia C., Revaud M.L., Allix M., Boulu R.G., Plotkine M. Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischemia in mice. Br. J. Pharmacol. 122:1997;625-630.
24. Hall E.D. Acute therapeutic interventions. Neurosurg. Clin. N. Am. 8:1997;195-206.
25. Halliwell B. Drug antioxidant effects. Drugs. 42:1991;569-605.
26. Free Radicals in Biology and Medicine. Halliwell B., Gutteridge J.M.C. Detection of Free Radicals and Other Reactive Species: Trapping and Fingerprinting. 3rd Edition: 1999;351-425 Oxford University Press Inc, New York. Part V.
27. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
28. Hara H., Huang P.L., Panahian N., Fishman M.C., Moskowitz M.A. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16:1996;605-611.
29. Hecker M., Preiss C., Klemm P., Busse R. Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br. J. Pharmacol. 118:1996;2178-2184.
30. Heinel L.A., Rubin S., Rosenwasser R.H., Vasthare U.S., Tuma R.F. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res. Bull. 34:1994;137-141.
31. Howard E.F., Chen Q., Cheng C., Carroll J.E., Hess D. NF-kB is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci. Lett. 248:1998;199-203.
32. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
33. Huang Z., Huang P.L., Ma J., et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:1996;981-987.
34. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268:1995;R286-R292.
35. Iadecola C., Zhang F., Xu S., Casey R., Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;378-384.
36. Iadecola C., Zhang F.G., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 27:1996;1373-1380.
37. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
38. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M.E. Delayed reduction of ischemic brain injury and neurologic deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
39. Jean W.C., Spellman S.R., Nussbaum E.S., Low W.C. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery. 43:1998;1382-1396.
40. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophil in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43:1999;860-878.
41. Kato H., Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell. Mol. Neurobiol. 19:1999;93-108.
42. Lee J.-M., Grabb M.C., Zipfel G.J., Choi D.W. Brain tissue responses to ischemia. J. Clin. Invest. 106:2000;723-731.
43. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
44. Love S. Oxidative stress in brain ischemia. Brain Pathol. 9:1999;119-131.
45. Margaill I., Allix M., Charriaut-Marlangue C., Boulu R.G., Plotkine M. Loss of NADPH-diaphorase containing neurons after reversible focal ischemia in rats delayed by L-NAME. Br. J. Pharmacol. 116:1995;2344-2345.
46. Margaill I., Mutel V., Allix M., et al. An antisense oligodeoxynucleotide to NOS 1 protects from transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17:1997;S88. suppl.
47. Matés J.M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 153:2000;83-104.
48. Matsuo Y., Onedora H., Shiga Y., et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
49. Matsuo Y., Onedora H., Shiga Y., et al. Role of cell adhesion in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656:1994;344-352.
50. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J. Cereb. Blood Flow Metab. 15:1995;941-947.
51. Memezawa H., Minamisawa H., Smith M.-L., Siesjö B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 89:1992;67-78.
52. Nagafuji T., Sugiyama M., Muto A., Makino T., Miyauchi T., Nabata H. The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. Neuroreport. 6:1995;1541-1545.
53. Nagasawa H., Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke. 20:1989;1037-1043.
54. Ogawa A., Yoshimoto T., Kikuchi H., et al. Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc. Dis. 9:1999;112-118.
55. O'Neill L.A.J., Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
56. Parmentier S., Böhme G.A., Lerouet D., et al. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br. J. Pharmacol. 127:1999;546-552.
57. Parmentier-Batteur S., Böhme G.A., Lerouet D., et al. Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J. Cereb. Blood Flow Metab. 21:2001;15-21.
58. Peuchen S., Bolaños J.P., Heales S.J.R., Almeida A., Duchen M.R., Clark J.B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52:1997;261-281.
59. Phillis J.W. A 'radical' view of cerebral ischemic injury. Prog. Neurobiol. 42:1994;441-448.
60. Prestigiacomo C.J., Kim S.C., Connolly E.S. Jr., Liao H., Yan S.F., Pinsky D.J. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke. 30:1999;1110-1117.
61. Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke. 28:1997;1283-1288.
62. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:2000;4904-4911.
63. Sharkey J., Kelly J.S., Butcher S.P. Inflammatory responses to cerebral ischemia. Ter Horst G.J., Korf J. Clinical Pharmacology of Cerebral Ischemia. Vol. 10:1996;235-263 Humana Press Inc, Totowa.
64. Small D.L., Morley P., Buchan A.M. Biology of ischemic cerebral cell death. Prog. Cardiovasc. Dis. 42:1999;185-207.
65. Szabó C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock. 6:1996;79-88.
66. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
67. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
68. Traber J., Suter M., Walter P., Richter C. In vivo modulation of total and mitochondrial glutathione in rat liver. Depletion by phorone and rescue by N-acetylcysteine. Biochem. Pharmacol. 43:1992;961-964.
69. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195.
70. Verrecchia C., Boulu R.G., Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neurone death. Adv. Neuroimmunol. 5:1995;359-378.
71. Wahl F., Allix M., Plotkine M., Boulu R.G. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke. 23:1992;267-272.
72. Wang X., Feuerstein G.Z. Role of immune and inflammatory mediators in CNS injury. Drug News Perspect. 13:2000;133-140.
73. Yamaguchi T., Sano K., Takakura K., et al. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen study group. Stroke. 29:1998;12-17.
74. Yanaka K., Camarata P.J., Spellman S.R., et al. Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocytes adhesion molecules. J. Cereb. Blood Flow Metab. 16:1996;1120-1125.
75. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decrease focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
76. Zhang R.L., Chopp M., Chen H., Garcia J.H. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125:1994;3-10.
77. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.
78. Zhang Z.G., Reif D., MacDonald J., et al. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;599-604.